Qingsong Capital
清松资本
Qingsong Capital (清松资本) is a healthcare-focused venture capital firm that appears to invest primarily in biotech, medical devices, and pharmaceutical services. Per 高榕创投's coverage, it has co-led or participated in multiple rounds across companies including surgical-robot maker Cornerstone Robotics (康诺思腾), CDMO firm ZhiXiang Biologics (智享生物), and biotech CasCade Therapeutics (凯思凯迪), often alongside institutions such as Gaorong Ventures, Qiming Venture Partners, and Eli Lilly Asia Ventures . A 2022 暗涌Waves piece also noted that an unnamed garment-factory family office had been a long-term LP in Qingsong Capital, among other healthcare boutique funds . The fund's own investment thesis, team composition, and vintage years are not detailed in elsewhere's current corpus.
AI-generated — may contain errors, please verify.
Coverage
CasCade Therapeutics Closes Nearly 500 Million Yuan Major Funding Round, Targeting Nuclear Receptor and GPCR Innovative Drug R&D
Dedicated to becoming a global leader in metabolic disease therapeutics.
高榕创投·Cornerstone Robotics Completes New Funding Round, Accelerating Global Expansion of High-Quality Chinese Surgical Robots
Where surgery brings peace of mind, life unfolds in all its vastness.
高榕创投·We Analyzed 1,000 LP Commitments and Found 30 Hidden Top Family Offices
They are also a microcosm of China's commercial evolution.
暗涌Waves·Multiple Innovative Companies Gain Global Recognition, Breakthroughs Achieved in Computational Biology, LiDAR, and Other Fields | Rongbao · July
Major events in July.
高榕创投·CDMO firm ZhiXiang Biologics raises over 500 million yuan in Series C funding to accelerate biopharma R&D for global clients
A one-stop CDMO platform for biologics R&D and manufacturing.
高榕创投·Rongbao · November | New milestones for drug R&D, chips, and autonomous driving; UJU Media lists on Hong Kong Stock Exchange Main Board
New funding, new products, new applications.
高榕创投·Cornerstone Robotics, a Leader in Innovative Surgical Robot Technology, Closes RMB 500 Million Series B Funding Round
We have completed a multi-pipeline layout covering soft-tissue surgical robots and other major specialty surgical robots.
高榕创投·
